Issue 2/2024
Content (13 Articles)
The Skin Microbiome and its Significance for Dermatologists
Cleo Whiting, Sara Abdel Azim, Adam Friedman
Targeted Systemic Therapies for Adults with Atopic Dermatitis: Selecting from Biologics and JAK Inhibitors
Richard W. Kim, Megan Lam, Katrina Abuabara, Eric L. Simpson, Aaron M. Drucker
Advancements in Bullous Pemphigoid Treatment: A Comprehensive Pipeline Update
Meropi Karakioulaki, Kilian Eyerich, Aikaterini Patsatsi
Recent Advances in Treatment of Systemic Sclerosis and Morphea
Noelle Teske, Nicole Fett
Rare Autoinflammatory Neutrophilic Dermatoses in Pregnancy: Literature Review
Angela Lo, Brittany Thompson, Naveed Sami
Pityriasis Rubra Pilaris: An Updated Review of Clinical Presentation, Etiopathogenesis, and Treatment Options
Tejas P. Joshi, Madeleine Duvic
Pressure and Skin: A Review of Disease Entities Driven or Influenced by Mechanical Pressure
Wei-Chen Chien, Tsen-Fang Tsai
Mucocutaneous Manifestations of Recreational Drug Use
Carolina V. Alexander-Savino, Ginat W. Mirowski, Donna A. Culton
Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program
Brett King, Jennifer Soung, Christos Tziotzios, Lidia Rudnicka, Pascal Joly, Melinda Gooderham, Rodney Sinclair, Natasha A. Mesinkovska, Carle Paul, Yankun Gong, Susan D. Anway, Helen Tran, Robert Wolk, Samuel H. Zwillich, Alexandre Lejeune
Guselkumab-Treated Patients with Plaque Psoriasis Who Achieved Complete Skin Clearance for ≥ 156 Consecutive Weeks: A Post-Hoc Analysis From the VOYAGE 1 Clinical Trial
Luis Puig, Antonio Costanzo, Elke M. G. J. de Jong, Tiago Torres, Richard B. Warren, Robert Wapenaar, Sven Wegner, Patricia Gorecki, Talia Gramiccia, Maria Jazra, Jozefien Buyze, Curdin Conrad
Real-World Use of Ruxolitinib Cream: Safety Analysis at 1 Year
Wilson Hu, Michele Thornton, Robert A. Livingston
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study
Tiago Torres, Andrea Chiricozzi, Luis Puig, Ana Maria Lé, Angelo Valerio Marzano, Paolo Dapavo, Esteban Dauden, Jόse-Manuel Carrascosa, Elizabeth Lazaridou, Gleison Duarte, André V. E. Carvalho, Ricardo Romiti, Natalia Rompoti, Laetitia Teixeira, Miguel Abreu, Elena Ippoliti, Carlo Alberto Maronese, Mar Llamas-Velasco, Eva Vilarrasa, Elena del Alcázar, Athina-Ioanna Daponte, Marina Papoutsaki, Andrea Carugno, Francesco Bellinato, Paolo Gisondi
Autoimmune and Cutaneous Inflammatory Comorbidities in Adult-Onset Morphea in the All of Us Research Program
Jill T. Shah, William Mark Richardson, Lavanya Mittal, Emily Hejazi, Daniel R. Mazori, Alisa N. Femia